Search is Powered by Google
Cancer / Oncology News

Improving Pregnancy Prospects After Cancer Treatment

Main Category: Cancer / Oncology
Also Included In: Pregnancy / Obstetrics;  Fertility
Article Date: 24 Apr 2008 - 3:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:3 and a half stars

3.08 (38 votes)

Health Professional:3 stars

2.78 (41 votes)

Article Opinions: 0 posts

It has been reported for the first time in Germany that healthy ovarian tissue has been taken from a non-pregnant woman with cancer and then re-implanted after cancer therapy. The patient is now 32 years old and could become pregnant as a result. This case is described by Ralf Dittrich and his colleagues from Erlangen University Hospital in the current issue of Deutsches Arzteblatt International (Dtsch Arztebl Int 2008; 105[15]: 274-8).

Anal carcinoma was diagnosed in this young patient in 2004 and chemotherapy followed by radiotherapy was recommended. As the ovaries lie near to the tumor, they are often damaged by therapy of this sort and the women become infertile. The Erlangen physicians succeeded in removing healthy ovarian tissue from the woman before treatment and to freeze it. The patient was then given the recommended cancer treatment. She tolerated this well and has not suffered any relapse. On the other hand, her menstrual periods had stopped, in spite of hormone treatment, for two years. For this reason, the patient's conserved ovarian material was inserted endoscopically into her pelvis. She subsequently reported her first menstruation. After this operation, it may be possible for her to become pregnant, although this has not happened yet.

The authors consider that the affected patients should be provided with more information, so that they are aware of this possibility of retaining fertility.

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59859

Accompanying Editorial:
http://www.aerzteblatt-international.de/v4/archiv/pdf.asp?id=59782

Source: Dr. Stephan Mertens
Deutsches Aerzteblatt International




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader




Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...

Add Your Advertisement Here